Top compounds associated with response to GRIN2D


Feature Type Standardized
Nominal ANOVA
mRNA DMOG GDSC1000 pan-cancer AAC -0.058 0.08
mRNA BRD8899 CTRPv2 pan-cancer AAC -0.07 0.08
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.087 0.08
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.092 0.08
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.08
mRNA YL54 CTRPv2 pan-cancer AAC -0.072 0.08
mRNA etomoxir CTRPv2 pan-cancer AAC 0.069 0.08
mRNA LAQ824 GDSC1000 pan-cancer AAC 0.06 0.08
mRNA Sunitinib FIMM pan-cancer AAC 0.3 0.08
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.08
Download CSV